“…Betulinic acid derivatives differ from natural cytostatics by low toxicity and selectivity of action on tumor cells [10]. New derivatives of betulonic acid synthesized at the Novosibirsk Institute of Organic Chemistry contain fragments of long-chain amino acids and peptides at C-28 and exhibit antiviral activity relative to human immunodeficiency virus type 1 and herpes simplex virus [4,5]. Previous experiments on cultured tumor cells of human melanoma and epidermal carcinoma showed that introduction of amino acid fragments into the molecule of betulinic acid (C-29) potentiates the cytotoxic effect of this compound [9].…”